HRTX Q2 2017 Earnings — Heron Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

HRTXHeron Therapeutics, Inc.

$153M

Q2 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$9M

Gross Profit

$7M88.1% margin

Operating Income

-$42M-494.2% margin

Net Income

-$43M-502.9% margin

EPS (Diluted)

$-0.80

QoQ Revenue Growth

+134.3%

Cash Flow

Operating Cash Flow

-$32M

Free Cash Flow

-$33M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$142M

Total Liabilities

$73M

Stockholders' Equity

$69M

Cash & Equivalents

$30M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$9M	$0	—
Gross Profit	$7M	-$27M	+127.5%
Operating Income	-$42M	-$43M	+2.3%
Net Income	-$43M	-$43M	+1.0%